Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
91 studies found for:    Narcolepsy
Show Display Options
Rank Status Study
21 Recruiting A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions: Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Interventions: Drug: BTD-001;   Drug: Placebo
22 Active, not recruiting A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem
23 Recruiting Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Conditions: Excessive Daytime Sleepiness;   Cataplexy;   Narcolepsy
Interventions: Drug: Sodium Oxybate;   Drug: Placebo
24 Unknown  Narcolepsy - New Potential Treatment
Condition: Narcolepsy
Interventions: Device: Kinetic Oscillation Stimulation Device;   Device: Kinetic Oscillation Stimulation Device in placebo mode
25 Completed A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
26 Completed
Has Results
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Conditions: Narcolepsy;   Sleep Apnea, Obstructive;   Sleep Apnea Syndromes;   Shift-Work Sleep Disorder
Intervention: Drug: CEP-10953 (Armodafinil)
27 Completed Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
Condition: Narcolepsy
Intervention: Drug: sodium oxybate
28 Enrolling by invitation "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
Conditions: Narcolepsy;   Obstructive Sleep Apnea
Intervention: Drug: JZP-110
29 Completed
Has Results
Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome;   Chronic Shift Work Sleep Disorder
Intervention: Drug: Armodafinil 100 to 250 mg/day
30 Completed Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Condition: Narcolepsy
Intervention: Drug: Modafinil
31 Completed Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Daytime Sleepiness;   Cataplexy;   Sleep Disorders
Interventions: Drug: BF2.649;   Drug: Modafinil;   Drug: Placebo
32 Completed
Has Results
Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Intervention: Drug: Armodafinil
33 Completed Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
Conditions: Narcolepsy;   Cataplexy;   Excessive Daytime Sleepiness
Interventions: Drug: BF2.649;   Drug: BF2.649 add on Modafinil
34 Active, not recruiting Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition
Condition: Narcolepsy
Intervention: Drug: Orexine A
35 Completed Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Sodium Oxybate (Xyrem)
36 Recruiting Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Conditions: Narcolepsy With Cataplexy;   Narcolepsy Without Cataplexy
Interventions: Drug: pitolisant;   Drug: Placebo
37 Recruiting The Effect of Caffeine on the Narcoleptic Patients
Condition: Narcolepsy
Interventions: Drug: Vivarin;   Drug: Fiber
38 Completed Provigil (Modafinil) Study by Taiwan Biotech Co.
Conditions: Narcolepsy;   Cataplexy;   Sleep Disorders;   Hypersomnolence;   Excessive Sleepiness
Intervention: Drug: Modafinil
39 Completed Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Condition: Narcolepsy
Intervention:
40 Recruiting Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
Condition: Narcolepsy
Interventions: Drug: THN102 300/3;   Drug: THN102 300/27;   Drug: Modafinil 300

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.